Untargeted serum metabolomics in systemic lupus erythematosus reveals candidate metabolomic signatures associated with clinical phenotypes and glucocorticoid use
ObjectivesDespite promising advances in metabolomics for biomarker discovery in systemic lupus erythematosus (SLE), studies examining associations with detailed disease phenotypes, including organ damage and validated outcome measures, remain limited. …